Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1910 1
1916 1
1919 1
1925 1
1929 1
1931 2
1936 2
1937 1
1938 1
1940 1
1942 2
1943 1
1944 2
1945 1
1946 1
1948 1
1950 2
1951 2
1952 2
1953 5
1954 1
1955 1
1956 2
1957 1
1958 5
1959 3
1960 2
1961 1
1962 5
1963 3
1964 4
1965 5
1966 3
1967 1
1968 4
1969 2
1970 1
1971 1
1972 5
1973 4
1974 1
1975 5
1976 11
1977 15
1978 16
1979 5
1980 8
1981 14
1982 11
1983 10
1984 14
1985 12
1986 18
1987 24
1988 29
1989 41
1990 36
1991 46
1992 64
1993 80
1994 58
1995 78
1996 67
1997 82
1998 83
1999 58
2000 79
2001 64
2002 64
2003 72
2004 87
2005 90
2006 89
2007 93
2008 89
2009 94
2010 95
2011 83
2012 90
2013 84
2014 89
2015 94
2016 74
2017 88
2018 59
2019 67
2020 77
2021 87
2022 90
2023 101
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

2,845 results

Results by year

Filters applied: . Clear all
Page 1
Generalized vaccinia.
GALLOWAY WH, MCBEAN LM. GALLOWAY WH, et al. Br Med J. 1956 Nov 10;2(5001):1102. doi: 10.1136/bmj.2.5001.1102. Br Med J. 1956. PMID: 13364397 Free PMC article. No abstract available.
Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.
Volz A, Sutter G. Volz A, et al. Adv Virus Res. 2017;97:187-243. doi: 10.1016/bs.aivir.2016.07.001. Epub 2016 Aug 1. Adv Virus Res. 2017. PMID: 28057259 Free PMC article. Review.
Safety tested Modified Vaccinia virus Ankara (MVA) is licensed as third-generation vaccine against smallpox and serves as a potent vector system for development of new candidate vaccines against infectious diseases and cancer. Historically, MVA was developed …
Safety tested Modified Vaccinia virus Ankara (MVA) is licensed as third-generation vaccine against smallpox and serves …
Vaccinia virus E3 prevents sensing of Z-RNA to block ZBP1-dependent necroptosis.
Koehler H, Cotsmire S, Zhang T, Balachandran S, Upton JW, Langland J, Kalman D, Jacobs BL, Mocarski ES. Koehler H, et al. Cell Host Microbe. 2021 Aug 11;29(8):1266-1276.e5. doi: 10.1016/j.chom.2021.05.009. Epub 2021 Jun 29. Cell Host Microbe. 2021. PMID: 34192517 Free PMC article.
Necroptosis mediated by Z-nucleic-acid-binding protein (ZBP)1 (also called DAI or DLM1) contributes to innate host defense against viruses by triggering cell death to eliminate infected cells. During infection, vaccinia virus (VACV) protein E3 prevents death signali …
Necroptosis mediated by Z-nucleic-acid-binding protein (ZBP)1 (also called DAI or DLM1) contributes to innate host defense against viruses b …
Generalized vaccinia.
STILLER R. STILLER R. Clin Proc Child Hosp Dist Columbia. 1946 Jun;2:157. Clin Proc Child Hosp Dist Columbia. 1946. PMID: 20996459 No abstract available.
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections.
Gilchuk I, Gilchuk P, Sapparapu G, Lampley R, Singh V, Kose N, Blum DL, Hughes LJ, Satheshkumar PS, Townsend MB, Kondas AV, Reed Z, Weiner Z, Olson VA, Hammarlund E, Raue HP, Slifka MK, Slaughter JC, Graham BS, Edwards KM, Eisenberg RJ, Cohen GH, Joyce S, Crowe JE Jr. Gilchuk I, et al. Cell. 2016 Oct 20;167(3):684-694.e9. doi: 10.1016/j.cell.2016.09.049. Cell. 2016. PMID: 27768891 Free PMC article.
Monkeypox (MPXV) and cowpox (CPXV) are emerging agents that cause severe human infections on an intermittent basis, and variola virus (VARV) has potential for use as an agent of bioterror. Vaccinia immune globulin (VIG) has been used therapeutically to treat severe …
Monkeypox (MPXV) and cowpox (CPXV) are emerging agents that cause severe human infections on an intermittent basis, and variola virus
Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism.
Pan Y, Tian T, Park CO, Lofftus SY, Mei S, Liu X, Luo C, O'Malley JT, Gehad A, Teague JE, Divito SJ, Fuhlbrigge R, Puigserver P, Krueger JG, Hotamisligil GS, Clark RA, Kupper TS. Pan Y, et al. Nature. 2017 Mar 9;543(7644):252-256. doi: 10.1038/nature21379. Epub 2017 Feb 20. Nature. 2017. PMID: 28219080 Free PMC article.
However, the biological pathways that enable the long-term survival of T(RM) cells are obscure. Here we show that mouse CD8(+) T(RM) cells generated by viral infection of the skin differentially express high levels of several molecules that mediate lipid uptake and intrace …
However, the biological pathways that enable the long-term survival of T(RM) cells are obscure. Here we show that mouse CD8(+) T(RM) cells …
Vaccinia virus morphogenesis and dissemination.
Roberts KL, Smith GL. Roberts KL, et al. Trends Microbiol. 2008 Oct;16(10):472-9. doi: 10.1016/j.tim.2008.07.009. Epub 2008 Sep 12. Trends Microbiol. 2008. PMID: 18789694 Review.
Vaccinia virus is the smallpox vaccine. It is the most intensively studied poxvirus, and its study has provided important insights about virus replication in general and the interactions of viruses with the host cell and immune system. Here, the entry,
Vaccinia virus is the smallpox vaccine. It is the most intensively studied poxvirus, and its study has provided important insi
Laboratory-acquired vaccinia infection.
Wlodaver CG, Palumbo GJ, Waner JL. Wlodaver CG, et al. J Clin Virol. 2004 Mar;29(3):167-70. doi: 10.1016/S1386-6532(03)00118-5. J Clin Virol. 2004. PMID: 14962785
BACKGROUND: Complications following vaccination with vaccinia virus have been well described but are not commonly observed. ...CONCLUSIONS: Exposure to vaccinia virus should raise the index of suspicion for patients with skin lesions. ...
BACKGROUND: Complications following vaccination with vaccinia virus have been well described but are not commonly observed. .. …
[GENERALIZED VACCINIA].
MARDAROWICZ C, MALEC R. MARDAROWICZ C, et al. Pol Tyg Lek. 1964 Aug 10;19:1249-50. Pol Tyg Lek. 1964. PMID: 14200544 Polish. No abstract available.
Generation of Recombinant Vaccinia Viruses.
Wyatt LS, Earl PL, Moss B. Wyatt LS, et al. Curr Protoc Protein Sci. 2017 Aug 1;89:5.13.1-5.13.18. doi: 10.1002/cpps.33. Curr Protoc Protein Sci. 2017. PMID: 28762491 Free PMC article.
This unit describes how to infect cells with vaccinia virus and then transfect them with a plasmid-transfer vector or PCR fragment to generate a recombinant virus. ...Finally, a method for live immunostaining that has been used primarily for detection …
This unit describes how to infect cells with vaccinia virus and then transfect them with a plasmid-transfer vector or PCR frag …
2,845 results